A P53-dependent Translational Program Directs Tissue-selective Phenotypes in a Model of Ribosomopathies
Overview
Reproductive Medicine
Authors
Affiliations
In ribosomopathies, perturbed expression of ribosome components leads to tissue-specific phenotypes. What accounts for such tissue-selective manifestations as a result of mutations in the ribosome, a ubiquitous cellular machine, has remained a mystery. Combining mouse genetics and in vivo ribosome profiling, we observe limb-patterning phenotypes in ribosomal protein (RP) haploinsufficient embryos, and we uncover selective translational changes of transcripts that controlling limb development. Surprisingly, both loss of p53, which is activated by RP haploinsufficiency, and augmented protein synthesis rescue these phenotypes. These findings are explained by the finding that p53 functions as a master regulator of protein synthesis, at least in part, through transcriptional activation of 4E-BP1. 4E-BP1, a key translational regulator, in turn, facilitates selective changes in the translatome downstream of p53, and this thereby explains how RP haploinsufficiency may elicit specificity to gene expression. These results provide an integrative model to help understand how in vivo tissue-specific phenotypes emerge in ribosomopathies.
Metabolic rewiring during bone development underlies tRNA m7G-associated primordial dwarfism.
Li Q, Jiang S, Lei K, Han H, Chen Y, Lin W J Clin Invest. 2024; 134(20).
PMID: 39255038 PMC: 11473147. DOI: 10.1172/JCI177220.
Decoding ribosome complexity: role of ribosomal proteins in cancer and disease.
Fuentes P, Pelletier J, Gentilella A NAR Cancer. 2024; 6(3):zcae032.
PMID: 39045153 PMC: 11263879. DOI: 10.1093/narcan/zcae032.
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence.
Cheng Y, Wang S, Zhang H, Lee J, Ni C, Guo J Cell. 2024; 187(17):4770-4789.e23.
PMID: 38981482 PMC: 11344685. DOI: 10.1016/j.cell.2024.06.019.
KDM2B is required for ribosome biogenesis and its depletion unequally affects mRNA translation.
Anastas V, Chavdoula E, La Ferlita A, Soysal B, Cosentini I, Nigita G bioRxiv. 2024; .
PMID: 38826406 PMC: 11142201. DOI: 10.1101/2024.05.22.595403.
Catalanotto C, Barbato C, Cogoni C, Benelli D Biomedicines. 2023; 11(11).
PMID: 38001969 PMC: 10669870. DOI: 10.3390/biomedicines11112969.